Piper Sandler Remains a Buy on Fifth Third Bancorp (FITB)
In a report released today, Scott Siefers from Piper Sandler maintained a Buy rating on Fifth Third Bancorp (FITB – Research Report), with a ...
Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA)
In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna (MRNA – Research Report), with a price target ...
Hosted on MSN17d
Goldman Sachs Downgrades Piper Sandler Companies (PIPR)
Fintel reports that on January 6, 2025, Goldman Sachs downgraded their outlook for Piper Sandler Companies (NYSE:PIPR) from Buy to Neutral. Analyst Price Forecast Suggests 25.14% Upside As of December ...